Back to Insider Trading View Full Company Profile

ZNTL

UNKNOWN

Zentalis Pharmaceuticals, Inc.

CIK: 0001725160

Strong Sell (90% confidence)

Last activity: 4 days ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Total Cash $33.90M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
Matrix Capital Management Company, LP
TEN_PERCENT_OWNER
0 1 -$9.97M
6,459,973 shares
$8.59M
WALTERS GROUP
TEN_PERCENT_OWNER
1 0 $7.75M
13,509,973 shares
$16.21M
Vultaggio Vincent
PAO and PFO
0 5 -$105K
146,506 shares
$355K
EASTLAND JULIA MARIE
CEO & President
0 2 -$21K
79,133 shares
$189K
Bruns Ingmar
Chief Medical Officer
0 2 -$8K
33,332 shares
$80K

Recent Transactions

SELL Vultaggio Vincent (PAO and PFO)

6,894 shares @ $2.42

$17K

Feb 10, 2026

Conviction: | View SEC Filing →
SELL Vultaggio Vincent (PAO and PFO)

3,379 shares @ $2.39

$8K

Feb 9, 2026

Conviction: | View SEC Filing →
SELL EASTLAND JULIA MARIE (CEO & President)

889 shares @ $2.39

$2K

Feb 9, 2026

Conviction: | View SEC Filing →
SELL Bruns Ingmar (Chief Medical Officer)

335 shares @ $2.39

$802

Feb 9, 2026

Conviction: | View SEC Filing →
SELL Vultaggio Vincent (PAO and PFO)

29,951 shares @ $2.43

$73K

Feb 6, 2026

Conviction: | View SEC Filing →
SELL EASTLAND JULIA MARIE (CEO & President)

7,866 shares @ $2.43

$19K

Feb 6, 2026

Conviction: | View SEC Filing →
SELL Bruns Ingmar (Chief Medical Officer)

2,962 shares @ $2.43

$7K

Feb 6, 2026

Conviction: | View SEC Filing →
SELL Vultaggio Vincent (PAO and PFO)

556 shares @ $2.52

$1K

Feb 3, 2026

Conviction: | View SEC Filing →
SELL Vultaggio Vincent (PAO and PFO)

2,540 shares @ $2.55

$6K

Feb 2, 2026

Conviction: | View SEC Filing →
BUY WALTERS GROUP (TEN_PERCENT_OWNER)

6,459,973 shares @ $1.20

$7.75M

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Matrix Capital Management Company, LP (TEN_PERCENT_OWNER)

7,500,000 shares @ $1.33

$9.97M

Dec 15, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.